These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 20876579)

  • 1. Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion.
    Tamboli IY; Barth E; Christian L; Siepmann M; Kumar S; Singh S; Tolksdorf K; Heneka MT; Lütjohann D; Wunderlich P; Walter J
    J Biol Chem; 2010 Nov; 285(48):37405-14. PubMed ID: 20876579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins in unconventional secretion of insulin-degrading enzyme and degradation of the amyloid-β peptide.
    Glebov K; Walter J
    Neurodegener Dis; 2012; 10(1-4):309-12. PubMed ID: 22205103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
    Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
    J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-degrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-beta degrading protease.
    Bulloj A; Leal MC; Xu H; Castaño EM; Morelli L
    J Alzheimers Dis; 2010; 19(1):79-95. PubMed ID: 20061628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
    Qiu WQ; Walsh DM; Ye Z; Vekrellis K; Zhang J; Podlisny MB; Rosner MR; Safavi A; Hersh LB; Selkoe DJ
    J Biol Chem; 1998 Dec; 273(49):32730-8. PubMed ID: 9830016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes.
    Kumar S; Singh S; Hinze D; Josten M; Sahl HG; Siepmann M; Walter J
    J Biol Chem; 2012 Mar; 287(11):8641-51. PubMed ID: 22267728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in AD.
    Tundo G; Ciaccio C; Sbardella D; Boraso M; Viviani B; Coletta M; Marini S
    PLoS One; 2012; 7(4):e34376. PubMed ID: 22509294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
    Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
    Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia.
    Yuyama K; Sun H; Mitsutake S; Igarashi Y
    J Biol Chem; 2012 Mar; 287(14):10977-89. PubMed ID: 22303002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE).
    Kilger E; Buehler A; Woelfing H; Kumar S; Kaeser SA; Nagarathinam A; Walter J; Jucker M; Coomaraswamy J
    J Biol Chem; 2011 Oct; 286(43):37446-57. PubMed ID: 21873424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CALHM1 ion channel elicits amyloid-β clearance by insulin-degrading enzyme in cell lines and in vivo in the mouse brain.
    Vingtdeux V; Chandakkar P; Zhao H; Blanc L; Ruiz S; Marambaud P
    J Cell Sci; 2015 Jul; 128(13):2330-8. PubMed ID: 25999473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1-42) by rat primary type 2 microglia.
    Shimizu E; Kawahara K; Kajizono M; Sawada M; Nakayama H
    J Immunol; 2008 Nov; 181(9):6503-13. PubMed ID: 18941241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-degrading enzyme is not secreted from cultured cells.
    Song ES; Rodgers DW; Hersh LB
    Sci Rep; 2018 Feb; 8(1):2335. PubMed ID: 29402917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
    Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
    J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
    Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
    J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway.
    Son SM; Kang S; Choi H; Mook-Jung I
    Mol Neurodegener; 2015 Oct; 10():56. PubMed ID: 26520569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medium-Chain Length Fatty Acids Enhance Aβ Degradation by Affecting Insulin-Degrading Enzyme.
    Mett J; Lauer AA; Janitschke D; Griebsch LV; Theiss EL; Grimm HS; Koivisto H; Tanila H; Hartmann T; Grimm MOW
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased amyloid-β pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice.
    Yuyama K; Sun H; Sakai S; Mitsutake S; Okada M; Tahara H; Furukawa J; Fujitani N; Shinohara Y; Igarashi Y
    J Biol Chem; 2014 Aug; 289(35):24488-98. PubMed ID: 25037226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.